Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours

V. Speirs, Stephen Atkin

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Production of vascular endothelial growth factor (VEGF) and expression of its receptors Flt-1 and KDR was determined in primary cultures of separated epithelial and stromal-enriched cultures derived from ten primary human breast carcinomas. By enzyme-linked immunosorbent assay, epithelial cells produced a mean VEGF of 33 ± 7 pg ml-1 μg-1 RNA (range 11-70). Stromal cells produced similar levels, with a mean of 48 ± 11 pg ml-1 μg-1 RNA (range 7-92). This was significantly greater than the amount produced by similar cultures derived from normal breast tissue (epithelial mean 19 ± 5 pg ml-1 μg-1 RNA, range 9-34, P < 0.05 vs tumour epithelial culture; stromal mean 26 ± 8 pg ml-1 μg-1 RNA, range 3-56). Flt-1 and KDR receptors were analysed by semi-quantitative reverse transcription polymerase chain reaction. Flt-1 was expressed by four of six epithelial and five of six stromal cultures. When expressed by both cell types, Flt-1 appeared to be significantly more abundant on stromal cells compared with epithelial cultures. Only a single tumour, a lobular carcinoma, failed to express Flt-1 on either cell type. With KDR, the reverse was true with constitutive expression of this receptor by epithelial cultures and zero or reduced (3/6) expression by stromal cultures. Differences in the expression pattern of VEGF receptors may reflect a differential response to VEGF by specific cell types. Thus, production of VEGF and expression of VEGF receptors Flt-1 and KDR by breast cancer epithelial and stromal cells suggests that VEGF may fulfil not only an angiogenic role, but also play a fundamental role as an autocrine/paracrine regulator in breast cancer, thereby facilitating tumour proliferation and subsequent invasion.

Original languageEnglish
Pages (from-to)898-903
Number of pages6
JournalBritish Journal of Cancer
Volume80
Issue number5-6
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Stromal Cells
Vascular Endothelial Growth Factor A
Epithelial Cells
Breast Neoplasms
RNA
Lobular Carcinoma
Neoplasms
Vascular Endothelial Growth Factor Receptor
Reverse Transcription
Breast
Epithelium
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction

Keywords

  • Angiogenesis
  • Breast
  • Cancer
  • VEGF

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{6894c9212f634e30bafe5901ff3cc2a5,
title = "Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours",
abstract = "Production of vascular endothelial growth factor (VEGF) and expression of its receptors Flt-1 and KDR was determined in primary cultures of separated epithelial and stromal-enriched cultures derived from ten primary human breast carcinomas. By enzyme-linked immunosorbent assay, epithelial cells produced a mean VEGF of 33 ± 7 pg ml-1 μg-1 RNA (range 11-70). Stromal cells produced similar levels, with a mean of 48 ± 11 pg ml-1 μg-1 RNA (range 7-92). This was significantly greater than the amount produced by similar cultures derived from normal breast tissue (epithelial mean 19 ± 5 pg ml-1 μg-1 RNA, range 9-34, P < 0.05 vs tumour epithelial culture; stromal mean 26 ± 8 pg ml-1 μg-1 RNA, range 3-56). Flt-1 and KDR receptors were analysed by semi-quantitative reverse transcription polymerase chain reaction. Flt-1 was expressed by four of six epithelial and five of six stromal cultures. When expressed by both cell types, Flt-1 appeared to be significantly more abundant on stromal cells compared with epithelial cultures. Only a single tumour, a lobular carcinoma, failed to express Flt-1 on either cell type. With KDR, the reverse was true with constitutive expression of this receptor by epithelial cultures and zero or reduced (3/6) expression by stromal cultures. Differences in the expression pattern of VEGF receptors may reflect a differential response to VEGF by specific cell types. Thus, production of VEGF and expression of VEGF receptors Flt-1 and KDR by breast cancer epithelial and stromal cells suggests that VEGF may fulfil not only an angiogenic role, but also play a fundamental role as an autocrine/paracrine regulator in breast cancer, thereby facilitating tumour proliferation and subsequent invasion.",
keywords = "Angiogenesis, Breast, Cancer, VEGF",
author = "V. Speirs and Stephen Atkin",
year = "1999",
doi = "10.1038/sj.bjc.6690438",
language = "English",
volume = "80",
pages = "898--903",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "5-6",

}

TY - JOUR

T1 - Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours

AU - Speirs, V.

AU - Atkin, Stephen

PY - 1999

Y1 - 1999

N2 - Production of vascular endothelial growth factor (VEGF) and expression of its receptors Flt-1 and KDR was determined in primary cultures of separated epithelial and stromal-enriched cultures derived from ten primary human breast carcinomas. By enzyme-linked immunosorbent assay, epithelial cells produced a mean VEGF of 33 ± 7 pg ml-1 μg-1 RNA (range 11-70). Stromal cells produced similar levels, with a mean of 48 ± 11 pg ml-1 μg-1 RNA (range 7-92). This was significantly greater than the amount produced by similar cultures derived from normal breast tissue (epithelial mean 19 ± 5 pg ml-1 μg-1 RNA, range 9-34, P < 0.05 vs tumour epithelial culture; stromal mean 26 ± 8 pg ml-1 μg-1 RNA, range 3-56). Flt-1 and KDR receptors were analysed by semi-quantitative reverse transcription polymerase chain reaction. Flt-1 was expressed by four of six epithelial and five of six stromal cultures. When expressed by both cell types, Flt-1 appeared to be significantly more abundant on stromal cells compared with epithelial cultures. Only a single tumour, a lobular carcinoma, failed to express Flt-1 on either cell type. With KDR, the reverse was true with constitutive expression of this receptor by epithelial cultures and zero or reduced (3/6) expression by stromal cultures. Differences in the expression pattern of VEGF receptors may reflect a differential response to VEGF by specific cell types. Thus, production of VEGF and expression of VEGF receptors Flt-1 and KDR by breast cancer epithelial and stromal cells suggests that VEGF may fulfil not only an angiogenic role, but also play a fundamental role as an autocrine/paracrine regulator in breast cancer, thereby facilitating tumour proliferation and subsequent invasion.

AB - Production of vascular endothelial growth factor (VEGF) and expression of its receptors Flt-1 and KDR was determined in primary cultures of separated epithelial and stromal-enriched cultures derived from ten primary human breast carcinomas. By enzyme-linked immunosorbent assay, epithelial cells produced a mean VEGF of 33 ± 7 pg ml-1 μg-1 RNA (range 11-70). Stromal cells produced similar levels, with a mean of 48 ± 11 pg ml-1 μg-1 RNA (range 7-92). This was significantly greater than the amount produced by similar cultures derived from normal breast tissue (epithelial mean 19 ± 5 pg ml-1 μg-1 RNA, range 9-34, P < 0.05 vs tumour epithelial culture; stromal mean 26 ± 8 pg ml-1 μg-1 RNA, range 3-56). Flt-1 and KDR receptors were analysed by semi-quantitative reverse transcription polymerase chain reaction. Flt-1 was expressed by four of six epithelial and five of six stromal cultures. When expressed by both cell types, Flt-1 appeared to be significantly more abundant on stromal cells compared with epithelial cultures. Only a single tumour, a lobular carcinoma, failed to express Flt-1 on either cell type. With KDR, the reverse was true with constitutive expression of this receptor by epithelial cultures and zero or reduced (3/6) expression by stromal cultures. Differences in the expression pattern of VEGF receptors may reflect a differential response to VEGF by specific cell types. Thus, production of VEGF and expression of VEGF receptors Flt-1 and KDR by breast cancer epithelial and stromal cells suggests that VEGF may fulfil not only an angiogenic role, but also play a fundamental role as an autocrine/paracrine regulator in breast cancer, thereby facilitating tumour proliferation and subsequent invasion.

KW - Angiogenesis

KW - Breast

KW - Cancer

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=0032897455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032897455&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6690438

DO - 10.1038/sj.bjc.6690438

M3 - Article

C2 - 10360672

AN - SCOPUS:0032897455

VL - 80

SP - 898

EP - 903

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 5-6

ER -